Health
Researchers in Japan compare two seroprevalence antibody tests for SARS-CoV-2 – News-Medical.Net
Researchers have shown that using reliable antibody tests in conjunction is an effective way to estimate seroprevalence in low prevalence settings.
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first emerged in Wuhan, China, in December 2019. It has since spread to 192 countries and territories, infecting over 100 million individuals and claiming over 2.2 million lives. To date, Japan has reported 391,945 cases and 5,833 deaths.
A team of researchers in Japan have developed commercially available antibody tests to estimate the seroprevalence of SARS-CoV-2 infection…
-
Noosa News21 hours agoRallies under way as nationwide support for Palestine surges
-
Noosa News22 hours agoHusband charged after beloved Brisbane nurse Carra Luke allegedly stabbed to death in Taigum home
-
General21 hours agoTens of thousands protest in nationwide action against war in Gaza
-
General24 hours agoNRL live updates: Newcastle Knights vs Brisbane Broncos, Wests Tigers vs North Queensland Cowboys — blog, scores and stats